McN-5292
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C18H18ClN |
| Molar mass | 283.80 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
McN-5292 is a stimulant drug which acts as a triple reuptake inhibitor, producing potent inhibition of the reuptake of all three monoamines, but around 10x selectivity for noradrenaline reuptake compared to dopamine and serotonin.[1][2]
Compound 22b in the table had Ki(nM): DA=1.7, NE=0.16, SER=1.5.
In terms of the SAR, it would be useful to compare for RTI-31 or RTI-113 for example.
See also
References
- ^ Mayer RA, Kindt MV, Heikkila RE (October 1986). "Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport". Journal of Neurochemistry. 47 (4): 1073–1079. doi:10.1111/j.1471-4159.1986.tb00722.x. PMID 3489072.
- ^ Maryanoff BE, McComsey DF, Gardocki JF, Shank RP, Costanzo MJ, Nortey SO, et al. (August 1987). "Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships". Journal of Medicinal Chemistry. 30 (8): 1433–1454. doi:10.1021/jm00391a028. PMID 3039136.